Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's potential to treat many of the most common types of cancer. Here is an overview of the data coming out of today's session:
Multiple Tumor Types:
Stomach & Gastrointestinal Cancer:
Come back for more updates from tomorrow's presentations.
ASCO17: Day 1 Immunotherapy Highlights
Read Previous Article
ASCO17: Day 3 Immunotherapy Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Happy Holidays from Team CRI! The best gift you can give is hope, and that's one you can give when you fundraise for the Cancer Research Institute this holiday season.
On Saturday, November 16, 2019, the Cancer Research Institute held its first Immunotherapy Patient Summit in Baltimore, in collaboration with the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.